Annis Gardner Whiting Capital Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10
Closed -$659 1348
2025
Q4
$659 Sell
10
-37
-79% -$2.28K ﹤0.01% 1093
2025
Q3
$3K Sell
47
-50
-52% -$3.49K ﹤0.01% 837
2025
Q2
$7.28K Buy
97
+50
+106% +$3.93K ﹤0.01% 792
2025
Q1
$4.18K Hold
47
﹤0.01% 640
2024
Q4
$4.33K Hold
47
﹤0.01% 623
2024
Q3
$5.3K Hold
47
﹤0.01% 628
2024
Q2
$4.64K Hold
47
﹤0.01% 779
2024
Q1
$4.75K Hold
47
﹤0.01% 765
2023
Q4
$4.26K Hold
47
﹤0.01% 564
2023
Q3
$3.64K Buy
+47
New +$3.9K ﹤0.01% 561

Other funds holding EMN

Annis Gardner Whiting Capital Advisors's EMN Position: Q1 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 10 shares — an estimated $659 sold.

Annis Gardner Whiting Capital Advisors first reported a position in EMN in Q3 2023 and held it in 10 quarters. The position peaked at $7.28K in Q2 2025. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 10 Eastman Chemical shares in Q1 2026, an estimated $659.
  • Annis Gardner Whiting Capital Advisors first reported a position in Eastman Chemical in Q3 2023 and held it in 10 quarters.
  • Annis Gardner Whiting Capital Advisors's Eastman Chemical position peaked at $7.28K in Q2 2025.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.